Medbox Inc (MDBX) 0.1490 $MDBX
Medbox and Shareholder Group Led by Founder Amend Voting Agreement
Filing Services Canada - Wed Aug 26, 8:03AM CDT
Medbox and Shareholder Group Led by Founder Amend Voting Agreement - Shareholder Group Voluntarily Cancels Shares, Effectively Relinquishing Majority Voting Position - Los Angeles, California (FSCwire) - Medbox, Inc. (OTCQB: MDBX (http://finance.yahoo.com/q?uhb=uh3_finance_vert&fr=&type=2button&s=MDBX%2C)), a provider of specialized services to the cannabis sector, including operators of dispensaries, cultivation centers, manufacturers and research facilities in those states where approved, today announced that Medbox and VM Group, a shareholder group led by its founder, P. Vincent Mehdizadeh, have agreed to amend a voting agreement in connection with the companys shares. Under terms of the voting agreement amendment, VM Group executed a majority shareholder consent to eliminate certain super voting rights from the companys Series A Preferred Stock, and further deferred VM Groups right to appoint a director to the companys board. The amendment also extended the expiration date of the voting agreement to July 2018, and the company agreed to accelerate the remaining $328,877 payments due on a promissory note to a member of VM Group. Medbox also announced that VM Group voluntarily cancelled and retired all of its two million Medbox preferred shares and three million of its Medbox common shares, effectively relinquishing VM Groups majority voting position. The action of VM Group has the effect of extending greater voting authority among all shareholders and should have a positive long-term impact on the companys corporate structure, said Jeff Goh, President and interim Chief Executive Officer of Medbox. As a management team, we will continue to focus our attention on growing the company and enhancing shareholder value, and aggressively pursuing the many opportunities that we believe are ahead for us in the burgeoning marijuana sector. About Medbox, Inc. Medbox, Inc., a leader in the rapidly emerging cannabis sector, provides specialized services to operators of dispensaries, cultivation centers, manufacturers and research facilities in those states where approved. Through trusted clients and affiliates, the company promotes efficient, consistent, high quality products that are priced right, readily available and safely packaged. For more information about the company or to explore partnership, please visit www.medbox.com. Forward-Looking Statements Certain statements in this press release constitute forward-looking statements within the meaning of federal securities laws. Such statements, including, but not limited to, VM Groups action having a positive long-term impact on the companys corporate structure, are based on current beliefs and expectations and are inherently subject to significant business, economic, regulatory and competitive uncertainties and contingencies, many of which are beyond the companys control. In addition, certain forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Potential risks and uncertainties also include, but are not limited to, regulatory developments in the industry, as well as political and economic conditions present within the industry. For a more detailed description of the risk factors associated with the company, please refer to the companys latest Annual Report on Form 10-K, and in particular, the section entitled Risk Factors therein, and in other periodic reports the company files with the Securities and Exchange Commission thereafter. The company does not assume any obligation to update any forward-looking statement to reflect events or developments after a forward-looking statement was made, unless required by law. For more information, contact: Janet Simmons PondelWilkinson Inc. 310-279-5980 pwinvestor@pondel.com To view this press release as a PDF file, click onto the following link: http://www.fscwire.com/sites/default/files/ne...262015.pdf Source: Medbox Inc. (OTCQB:MDBX) http://www.thedispensingsolution.com/ Maximum News Dissemination by FSCwire. http://www.fscwire.com Copyright(C)2015 Filing Services Canada Inc.
Medbox Founder & Majority Shareholder Retires 13 Million MDBX Shares for the Benefit of the Shareholders
Thomson Reuters ONE - Wed Aug 26, 7:30AM CDT
LOS ANGELES, Aug. 26, 2015 (GLOBE NEWSWIRE) -- P. Vincent Mehdizadeh, Founder and now former majority shareholder of Medbox, Inc. (OTCQB:MDBX) announced retiring 13 million shares of MDBX, including all 2 million preferred shares in his possession, carrying 5 to 1 conversion to common shares and super voting rights, along with an additional 3 million common shares. The shares have been retired, or in effect cancelled, resulting in 13 million less shares issued and outstanding on a fully diluted basis.
Medbox Completes $4.5-Million Financing
ACCESSWIRE - Tue Aug 25, 8:45AM CDT
Funds to be used for Corporate Purposes, Including Further Implementation of Strategic Growth Plan
Medbox Engages Israel-Based Medical Marijuana Consultancy, as Company Prepares to Enter Cultivation Market
Filing Services Canada - Thu Aug 20, 3:09PM CDT
Medbox Engages Israel-Based Medical Marijuana Consultancy, as Company Prepares to Enter Cultivation Market Los Angeles, California (FSCwire) - Medbox, Inc. (OTCQB: MDBX), a provider of specialized services to the cannabis sector, including operators of dispensaries, cultivation centers, manufacturers and research facilities in those states where approved, today announced it has engaged an experienced Israel-based medical marijuana consultancy, as it prepares to enter the cultivation market and work with licensed independent growers. After 30 years of cannabis industry experience in the United States, Israel and Europe, Avner Barak, co-founder of Cannguru Agrotechnic Consulting Ltd. (CAC), recently was brought on to consult with Medbox on proprietary true-to-type genetics, expert cultivation techniques and business development opportunities. Barak is currently co-leading Canndoc, which is one of eight licensed growers supplying medicine to thousands of Israeli patients and has operated a medical cannabis farm in Israel since 2009 for the Israel Ministry of Health. We are aligning ourselves with world class experts, as we enter a new phase in our companys development, said Jeff Goh, President and interim Chief Executive Officer of Medbox. It is critical that products produced on our property by licensed independent growers be of the highest pharmaceutical quality to ensure efficacy and consistency for patients, as well as to drive sustainable revenues. After an exhaustive review of global industry experts, we selected CAC and Barak based on their experience and long history of success, guiding physicians, nurses, academic researchers and others, in a country known for its scientific and medical prowess. The solid reputation Barak has built among growers, harvesters and research developers, as well as working closely with hospitals and healthcare professionals in Israel, will provide a significant benefit to Medbox and to our customers, Goh added. Barak said, We are impressed with the Medbox management team and strategy as it enters and begins to penetrate the cultivation market. Our master growers and expert extractors look forward to doing our part to promote quality, and, in turn, to help Medbox build its professional and leadership stature. Medbox recently announced that it expects marijuana cultivation by a licensed independent grower to begin on a recently purchased property in Pueblo, Colorado in the first quarter of 2016, with initial revenues from marijuana cultivation starting in mid-2016. The company completed the purchase of 320 acres of farmland in Pueblo in early August. About Medbox, Inc. Medbox, Inc., a leader in the rapidly emerging cannabis sector, provides specialized services to operators of dispensaries, cultivation centers, manufacturers and research facilities in those states where approved. Through trusted clients and affiliates, the company promotes efficient, consistent, high quality products that are priced right, readily available and safely packaged. For more information about the company or to explore partnership, please visit www.medbox.com (http://www.medbox.com). Forward-Looking Statements Certain statements in this press release constitute forward-looking statements within the meaning of federal securities laws. Such statements, including, but not limited to, the start of marijuana cultivation by a licensed independent grower and initial revenues, are based on current beliefs and expectations and are inherently subject to significant business, economic, regulatory and competitive uncertainties and contingencies, many of which are beyond the companys control. In addition, certain forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Potential risks and uncertainties also include, but are not limited to, regulatory developments in the industry, as well as political and economic conditions present within the industry. For a more detailed description of the risk factors associated with the company, please refer to the companys latest Annual Report on Form 10-K, and in particular, the section entitled Risk Factors therein, and in other periodic reports the company files with the Securities and Exchange Commission thereafter. The company does not assume any obligation to update any forward-looking statement to reflect events or developments after a forward-looking statement was made, unless required by law. For more information, contact: Janet Simmons PondelWilkinson Inc. 310-279-5980 investor@pondel.com To view this press release as a PDF file, click onto the following link: http://fscwire.com/sites/default/files/news_r...202015.pdf Source: Medbox Inc. (OTCQB:MDBX) http://www.thedispensingsolution.com/ Maximum News Dissemination by FSCwire. http://www.fscwire.com Copyright(C)2015 Filing Services Canada Inc.
DigiPath is Well-Positioned as Nevada Considers Adult-Use Legalization
ACCESSWIRE - Mon Aug 17, 10:16AM CDT
SEATTLE, WA / ACCESSWIRE / August 17, 2015 / DigiPath Inc. (OTCQB: DIGP), a leading provider of laboratory testing, education programs, and unbiased news coverage to the burgeoning cannabis industry, has become a leading player in Nevada's medical marijuana market with the opening of its testing laboratory earlier this year. Equipped with state-of-the-art analytical instrumentation and operated under the direction of Cindy Orser, Ph.D., the facility provides growers and manufacturers with reliable testing data.
Medbox Reports 2015 Second Quarter Financial Results
Filing Services Canada XHTML - Fri Aug 14, 6:29PM CDT
Medbox Issues Clarification and Amplification Re Purchase of 320 Acres of Land in Colorado
Filing Services Canada XHTML - Mon Aug 10, 4:05PM CDT
Medbox Closes Escrow, Completes Agreement To Purchase 320-Acres of Agricultural Land in Colorado
Filing Services Canada XHTML - Mon Aug 10, 8:01AM CDT
Lexaria's ViPova Isn't Your Average CBD Product
ACCESSWIRE - Mon Jul 27, 8:15AM CDT
SEATTLE, WA / ACCESSWIRE / July 27, 2015 / The cannabis industry could be worth $35 billion by 2020, according to GreenWave Advisors, and the majority of the revenue is likely coming from early adopters. As existing users of cannabis and cannabinoid extracts, they already know the difference between tetrahydrocannabinol ("THC"
, cannabidiol ("CBD" , and other cannabinoids, as well as the difference between various strains of marijuana, such as Charlotte's Web.
Medbox and Shareholder Group Led by Founder Amend Voting Agreement
Filing Services Canada - Wed Aug 26, 8:03AM CDT
Medbox and Shareholder Group Led by Founder Amend Voting Agreement - Shareholder Group Voluntarily Cancels Shares, Effectively Relinquishing Majority Voting Position - Los Angeles, California (FSCwire) - Medbox, Inc. (OTCQB: MDBX (http://finance.yahoo.com/q?uhb=uh3_finance_vert&fr=&type=2button&s=MDBX%2C)), a provider of specialized services to the cannabis sector, including operators of dispensaries, cultivation centers, manufacturers and research facilities in those states where approved, today announced that Medbox and VM Group, a shareholder group led by its founder, P. Vincent Mehdizadeh, have agreed to amend a voting agreement in connection with the companys shares. Under terms of the voting agreement amendment, VM Group executed a majority shareholder consent to eliminate certain super voting rights from the companys Series A Preferred Stock, and further deferred VM Groups right to appoint a director to the companys board. The amendment also extended the expiration date of the voting agreement to July 2018, and the company agreed to accelerate the remaining $328,877 payments due on a promissory note to a member of VM Group. Medbox also announced that VM Group voluntarily cancelled and retired all of its two million Medbox preferred shares and three million of its Medbox common shares, effectively relinquishing VM Groups majority voting position. The action of VM Group has the effect of extending greater voting authority among all shareholders and should have a positive long-term impact on the companys corporate structure, said Jeff Goh, President and interim Chief Executive Officer of Medbox. As a management team, we will continue to focus our attention on growing the company and enhancing shareholder value, and aggressively pursuing the many opportunities that we believe are ahead for us in the burgeoning marijuana sector. About Medbox, Inc. Medbox, Inc., a leader in the rapidly emerging cannabis sector, provides specialized services to operators of dispensaries, cultivation centers, manufacturers and research facilities in those states where approved. Through trusted clients and affiliates, the company promotes efficient, consistent, high quality products that are priced right, readily available and safely packaged. For more information about the company or to explore partnership, please visit www.medbox.com. Forward-Looking Statements Certain statements in this press release constitute forward-looking statements within the meaning of federal securities laws. Such statements, including, but not limited to, VM Groups action having a positive long-term impact on the companys corporate structure, are based on current beliefs and expectations and are inherently subject to significant business, economic, regulatory and competitive uncertainties and contingencies, many of which are beyond the companys control. In addition, certain forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Potential risks and uncertainties also include, but are not limited to, regulatory developments in the industry, as well as political and economic conditions present within the industry. For a more detailed description of the risk factors associated with the company, please refer to the companys latest Annual Report on Form 10-K, and in particular, the section entitled Risk Factors therein, and in other periodic reports the company files with the Securities and Exchange Commission thereafter. The company does not assume any obligation to update any forward-looking statement to reflect events or developments after a forward-looking statement was made, unless required by law. For more information, contact: Janet Simmons PondelWilkinson Inc. 310-279-5980 pwinvestor@pondel.com To view this press release as a PDF file, click onto the following link: http://www.fscwire.com/sites/default/files/ne...262015.pdf Source: Medbox Inc. (OTCQB:MDBX) http://www.thedispensingsolution.com/ Maximum News Dissemination by FSCwire. http://www.fscwire.com Copyright(C)2015 Filing Services Canada Inc.
Medbox Founder & Majority Shareholder Retires 13 Million MDBX Shares for the Benefit of the Shareholders
Thomson Reuters ONE - Wed Aug 26, 7:30AM CDT
LOS ANGELES, Aug. 26, 2015 (GLOBE NEWSWIRE) -- P. Vincent Mehdizadeh, Founder and now former majority shareholder of Medbox, Inc. (OTCQB:MDBX) announced retiring 13 million shares of MDBX, including all 2 million preferred shares in his possession, carrying 5 to 1 conversion to common shares and super voting rights, along with an additional 3 million common shares. The shares have been retired, or in effect cancelled, resulting in 13 million less shares issued and outstanding on a fully diluted basis.
Medbox Completes $4.5-Million Financing
ACCESSWIRE - Tue Aug 25, 8:45AM CDT
Funds to be used for Corporate Purposes, Including Further Implementation of Strategic Growth Plan
Medbox Engages Israel-Based Medical Marijuana Consultancy, as Company Prepares to Enter Cultivation Market
Filing Services Canada - Thu Aug 20, 3:09PM CDT
Medbox Engages Israel-Based Medical Marijuana Consultancy, as Company Prepares to Enter Cultivation Market Los Angeles, California (FSCwire) - Medbox, Inc. (OTCQB: MDBX), a provider of specialized services to the cannabis sector, including operators of dispensaries, cultivation centers, manufacturers and research facilities in those states where approved, today announced it has engaged an experienced Israel-based medical marijuana consultancy, as it prepares to enter the cultivation market and work with licensed independent growers. After 30 years of cannabis industry experience in the United States, Israel and Europe, Avner Barak, co-founder of Cannguru Agrotechnic Consulting Ltd. (CAC), recently was brought on to consult with Medbox on proprietary true-to-type genetics, expert cultivation techniques and business development opportunities. Barak is currently co-leading Canndoc, which is one of eight licensed growers supplying medicine to thousands of Israeli patients and has operated a medical cannabis farm in Israel since 2009 for the Israel Ministry of Health. We are aligning ourselves with world class experts, as we enter a new phase in our companys development, said Jeff Goh, President and interim Chief Executive Officer of Medbox. It is critical that products produced on our property by licensed independent growers be of the highest pharmaceutical quality to ensure efficacy and consistency for patients, as well as to drive sustainable revenues. After an exhaustive review of global industry experts, we selected CAC and Barak based on their experience and long history of success, guiding physicians, nurses, academic researchers and others, in a country known for its scientific and medical prowess. The solid reputation Barak has built among growers, harvesters and research developers, as well as working closely with hospitals and healthcare professionals in Israel, will provide a significant benefit to Medbox and to our customers, Goh added. Barak said, We are impressed with the Medbox management team and strategy as it enters and begins to penetrate the cultivation market. Our master growers and expert extractors look forward to doing our part to promote quality, and, in turn, to help Medbox build its professional and leadership stature. Medbox recently announced that it expects marijuana cultivation by a licensed independent grower to begin on a recently purchased property in Pueblo, Colorado in the first quarter of 2016, with initial revenues from marijuana cultivation starting in mid-2016. The company completed the purchase of 320 acres of farmland in Pueblo in early August. About Medbox, Inc. Medbox, Inc., a leader in the rapidly emerging cannabis sector, provides specialized services to operators of dispensaries, cultivation centers, manufacturers and research facilities in those states where approved. Through trusted clients and affiliates, the company promotes efficient, consistent, high quality products that are priced right, readily available and safely packaged. For more information about the company or to explore partnership, please visit www.medbox.com (http://www.medbox.com). Forward-Looking Statements Certain statements in this press release constitute forward-looking statements within the meaning of federal securities laws. Such statements, including, but not limited to, the start of marijuana cultivation by a licensed independent grower and initial revenues, are based on current beliefs and expectations and are inherently subject to significant business, economic, regulatory and competitive uncertainties and contingencies, many of which are beyond the companys control. In addition, certain forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Potential risks and uncertainties also include, but are not limited to, regulatory developments in the industry, as well as political and economic conditions present within the industry. For a more detailed description of the risk factors associated with the company, please refer to the companys latest Annual Report on Form 10-K, and in particular, the section entitled Risk Factors therein, and in other periodic reports the company files with the Securities and Exchange Commission thereafter. The company does not assume any obligation to update any forward-looking statement to reflect events or developments after a forward-looking statement was made, unless required by law. For more information, contact: Janet Simmons PondelWilkinson Inc. 310-279-5980 investor@pondel.com To view this press release as a PDF file, click onto the following link: http://fscwire.com/sites/default/files/news_r...202015.pdf Source: Medbox Inc. (OTCQB:MDBX) http://www.thedispensingsolution.com/ Maximum News Dissemination by FSCwire. http://www.fscwire.com Copyright(C)2015 Filing Services Canada Inc.
DigiPath is Well-Positioned as Nevada Considers Adult-Use Legalization
ACCESSWIRE - Mon Aug 17, 10:16AM CDT
SEATTLE, WA / ACCESSWIRE / August 17, 2015 / DigiPath Inc. (OTCQB: DIGP), a leading provider of laboratory testing, education programs, and unbiased news coverage to the burgeoning cannabis industry, has become a leading player in Nevada's medical marijuana market with the opening of its testing laboratory earlier this year. Equipped with state-of-the-art analytical instrumentation and operated under the direction of Cindy Orser, Ph.D., the facility provides growers and manufacturers with reliable testing data.
Medbox Reports 2015 Second Quarter Financial Results
Filing Services Canada XHTML - Fri Aug 14, 6:29PM CDT
Medbox Issues Clarification and Amplification Re Purchase of 320 Acres of Land in Colorado
Filing Services Canada XHTML - Mon Aug 10, 4:05PM CDT
Medbox Closes Escrow, Completes Agreement To Purchase 320-Acres of Agricultural Land in Colorado
Filing Services Canada XHTML - Mon Aug 10, 8:01AM CDT
Lexaria's ViPova Isn't Your Average CBD Product
ACCESSWIRE - Mon Jul 27, 8:15AM CDT
SEATTLE, WA / ACCESSWIRE / July 27, 2015 / The cannabis industry could be worth $35 billion by 2020, according to GreenWave Advisors, and the majority of the revenue is likely coming from early adopters. As existing users of cannabis and cannabinoid extracts, they already know the difference between tetrahydrocannabinol ("THC"
, cannabidiol ("CBD" , and other cannabinoids, as well as the difference between various strains of marijuana, such as Charlotte's Web. 
